Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela S Becker

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Blood|January 23, 2025
VenEx precisely predicts ven-aza responsePamela S Becker
Blood Cancer Discovery|October 12, 2023
Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug ScreeningPamela S Becker
Thescientificworldjournal|February 21, 2012
Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironmentPamela S Becker
Current Hematology Reports|October 22, 2004
Growth factor priming in therapy of acute myelogenous leukemiaPamela S Becker
Cancer|July 13, 2025
Allogeneic transplantation provides added benefit to FMS-like tyrosine kinase 3 (FLT3) inhibitors for both low-intensity and high-intensity regimens in FLT3-mutated acute myeloid leukemiaPamela S Becker
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Genetic predisposition for chemotherapy-induced neuropathy in multiple myelomaPamela S Becker
Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
Optimizing stem cell mobilization: lessons learnedPamela S Becker
Acta Haematologica|November 5, 2005
The current status of gene therapy in autologous transplantationPamela S Becker
Journal of Cellular Biochemistry. Supplement|June 6, 2002
Hematopoietic stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challengesPamela S Becker
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
The Role of BiosimilarsAndrew D Zelenetz, Pamela S Becker
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Blood|January 23, 2025
VenEx precisely predicts ven-aza responsePamela S Becker
Blood Cancer Discovery|October 12, 2023
Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug ScreeningPamela S Becker
Thescientificworldjournal|February 21, 2012
Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironmentPamela S Becker
Current Hematology Reports|October 22, 2004
Growth factor priming in therapy of acute myelogenous leukemiaPamela S Becker
Cancer|July 13, 2025
Allogeneic transplantation provides added benefit to FMS-like tyrosine kinase 3 (FLT3) inhibitors for both low-intensity and high-intensity regimens in FLT3-mutated acute myeloid leukemiaPamela S Becker
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Genetic predisposition for chemotherapy-induced neuropathy in multiple myelomaPamela S Becker
Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
Optimizing stem cell mobilization: lessons learnedPamela S Becker
Acta Haematologica|November 5, 2005
The current status of gene therapy in autologous transplantationPamela S Becker
Journal of Cellular Biochemistry. Supplement|June 6, 2002
Hematopoietic stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challengesPamela S Becker
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
The Role of BiosimilarsAndrew D Zelenetz, Pamela S Becker
Pageof 14